The approval was supported by a systematic review of published literature that included 46 patients with FOLR1-CFTD treated with leucovorin through various administration routes. The Food and Drug ...
Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...
Share on Pinterest More research is still needed before leucovorin should be approved as an autism treatment. Westend61/Getty Images Federal regulators have approved leucovorin for the treatment of ...
Scientists have learned more about the genetic factors that may underlie double-jointedness, also known as hypermobility, and diseases that affect connective tissue called hypermobile Ehlers-Danlos ...
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has approved expanded use of Wellcovorin (leucovorin calcium) tablets for the treatment of cerebral folate deficiency in adult and ...
US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for autism, adding another twist to the unusual story of a decades-old drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results